Department(s) concerned
Childhood and adolescent cancers
Childhood cancers are not like adult cancers . They are much rarer (1% to 2% of all cancers) and often affect different organs than adult cancers. Leukemia, central nervous system tumors, and lymphomas are the main types of cancer found in children under 15, unlike the main adult cancers, which more frequently affect the lungs, breast, or prostate.
Advances in healthcare and new therapies over the past four decades have made it possible to cure 8 out of 10 children. Despite significant progress, cancer remains the second leading cause of death in children under 15, after accidents. Research must continue to develop new treatments that improve the prognosis of pediatric cancers and limit their long-term effects , as well as better identify their causes in order to improve prevention. France's ten-year cancer control strategy (2021-2030) includes numerous initiatives to achieve these objectives.
Support
Offering comprehensive and varied care, the pediatric onco-hematology department at CHU Caen Normandie is a nationally recognized reference and referral service in the fight against pediatric cancers.
In 2023, it welcomed around forty children from across the former Lower Normandy region. Furthermore, it also participated in the care of 30 children from other departments and regions, within the framework of interregional care pathways.
With 15 beds (including 4 day hospital beds), the service carried out nearly 2,500 stays in 2023, 80% of which were outpatient.
The care pathway for children and adolescents treated at the University Hospital is organized with the OncoNormandie pediatric network, in close collaboration with the pediatric departments of other hospitals in the region and pediatric rehabilitation centers. It involves significant coordination between the various medical (pediatric surgeons, neurosurgeons, pediatric intensivists, radiologists, radiation oncologists, rehabilitation physicians, geneticists, pharmacists, etc.) and paramedical (nurses, nursing assistants, psychologists, social workers, teachers, coordinating nurses, clinical research assistants, etc.) professionals who may be involved during the care pathway or treatments.
The medical and paramedical team is integrated into the Grand Ouest Interregional Childhood Cancer Network, which aims to improve clinical research and training development. As such, it actively participates in research and the use of innovative therapies, and approximately thirty clinical trials are currently underway in the unit. In 2023, 75% of the children treated in the department were enrolled in clinical trial protocols or participated in clinical research, facilitating this population's access to innovative therapies (targeted therapies). Paramedical research is also being developed to improve the quality of patient care.
|
Hospital Practitioner
|
|
healthcare manager
|
|
Hospital Practitioner
|
|
Hospital Practitioner
|
|
Hospital practitioner
|
Awareness
Raising public awareness of the realities of childhood cancer is essential to advancing research, improving treatments, and providing optimal support for patients and their families. "Golden September" offers a unique opportunity to get involved and make a real difference in the lives of these courageous children. Every donation counts and helps support research, medical care, and projects such as the Family House.
Join us and donate now to support Gold September and the Caen Normandy University Hospital Foundation in their commitment to children with pediatric cancer. Your donations are essential to advancing research, improving treatments, and providing optimal support to patients and their families. Together, we can give these children the support and hope they need to face this challenge.
Press contact
Avenue de la Côte de Nacre,
CS 30001
, 14033 CAEN cedex 9
